Skip to content

Traditional Chinese Medicine (TCM) constitution and the cardiovascular risks in patients with obstructive sleep apnea syndrome (OSAS).

For patients with obstructive sleep apnea syndrome, what kinds of constitution in Traditional Chinese Medicine (TCM) are they have, and what is the relationship between constitution in Traditional Chinese Medicine (TCM) and cardiovascular disease.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12612001280897
Enrollment
50
Registered
2012-12-11
Start date
2011-09-16
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Obstructive sleep apnea syndrome (OSAS) is composed of sleeping apnea and hypopnea. It also accompanied with fatigue, daytime sleepiness and poor concentration and memory in such patients. It was known that OSAS is associated with higher occurrence of cardiovascular disease. In traditional Chinese medicine aspect, OSAS has three major subtypes and has corresponding treatment. In this study we will observe on their TCM constitution and their cardiovascular complications in patients with OSAS.

Interventions

Observation: 1. constitution in Traditional Chinese Medicine (TCM), a constitution's classification which is defined in TCM method and use to evaluate patient's constitution; 2. status of sleepiness; 3. quality of life; 4. endothelial function; 5. severity of OSAS. Participants are assessed at baseline only for about 9 hours (including an overnight sleep study)

Sponsors

Taoyuan Chang Gung Memorial Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

patients with suspected obstructive sleep apnea syndrome

Exclusion criteria

with underlying diseases of chronic obstructive pulmonary disease, myocardial infarction, heart failure, stroke, liver diseases, kidney diseases, neurogic and muscular disorders, metabolic diseases, immunosuppressed diseases, and malignancy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026